Importance of ethics and methodology in clinical trials during the COVID-19 pandemic

Brando Ortiz-Saavedra; Zhamanda N Ortiz-Benique

2022, Number 1

<< Back Next >>

Med Int Mex 2022; 38 (1)

Importance of ethics and methodology in clinical trials during the COVID-19 pandemic

Ortiz-Saavedra B, Ortiz-Benique ZN

Full text

How to cite this article

Language: Spanish
References: 10
Page: 214-216
PDF size: 155.51 Kb.

Text Extraction

No abstract.

REFERENCES

Lugo-Zamudio G, Navarrete-Martínez LB, Hernández-Salazar C, Reyes-Rodríguez FG, et al. Tratamiento ambulatorio con cloroquina en pacientes con sospecha de COVID-19 para la reducción de los síntomas asociados con la infección. Med Int Méx 2021; 37 (3): 359-365. doi. 10.24245/mim.v37i3.4798.
Park JJH, Mogg R, Smith GE, Nakimuli-Mpungu E, Jehan F, Rayner CR, et al. How COVID-19 has fundamentally changed clinical research in global health. The Lancet Global Health 2021; 9 (5): e711-e20. doi. 10.1016/S2214-109X(20)30542-8.
Association WM. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA 2013; 310 (20): 2191-4. doi. 10.1001/jama.2013.281053.
World Health Organization. Clinical Trials . WHO | World Health Organization. 2020 . Available from: https://www.who.int/news-room/q-a-detail/clinical-trials.
Kinser PA, Robins JL. Control group design: enhancing rigor in research of mind-body therapies for depression. Evid Based Complement Alternat Med 2013; 2013: 140467. doi. 10.1155/2013/140467.
Althubaiti A. Information bias in health research: definition, pitfalls, and adjustment methods. J Multidiscip Healthc 2016; 9: 211-7. doi. 10.2147/JMDH.S104807.
Hashem H, Abufaraj M, Tbakhi A, Sultan I. Obstacles and considerations related to clinical trial research during the COVID-19 Pandemic. 2020; 7 (598038). doi. 10.3389/fmed.2020.598038.
U.S. Food and Drug Administration. FDA cautions use of hydroxychloroquine/chloroquine for COVID-19 . U.S. Food & Drug Administration. 2020 . Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or.
Robb CT, Goepp M, Rossi AG, Yao C. Non-steroidal anti-inflammatory drugs, prostaglandins, and COVID-19. Br J Pharmacol 2020; 177 (21): 4899-920. doi. 10.1111/bph.15206.
Lantos JD, Wendler D, Septimus E, Wahba S, Madigan R, Bliss G. Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials. Clin Trials 2015; 12 (5): 485-93. doi. 10.1177/1740774515597687.